1 selected, source-linked Pramlintide records carrying a 2006 source date. This is a navigational view of PeptideScanner’s selected coverage—not a complete research timeline or a statement about safety or effectiveness.
The Federal Register published notice E6-9414, attributed to FDA and its parent HHS department, on 2006-06-16. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; SYMLIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Pramlintide.